NEW TAIPEI CITY, Jan. 23, 2024 /PRNewswire/ — Caliway Biopharmaceuticals (Caliway) announces that Australian Bellberry HREC has approved Caliway’s application to initiate CBL-514’s Pivotal Phase 3 study (CBL-0301 Phase 3) for subcutaneous fat reduction. “We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the […]
to Further Increase Production Capacity and Enhance Testing Capabilities CHANGSHU, China, Jan. 23, 2024 /PRNewswire/ — Nexteer Automotive held a groundbreaking ceremony today for its new manufacturing campus located in the Changshu Economic and Technology Development Zone. Nexteer’s strategic expansion in Changshu will increase the company’s production and testing capacity in China, while further strengthening Nexteer’s […]
FRISCO, Texas, Jan. 23, 2024 /PRNewswire/ — Baird Medical Devices, Inc. (“Baird Medical” or the “Company”), a leading microwave ablation (“MWA”) medical device developer and provider in China and the United States, today announced that it has performed its first thyroid MWA procedure in the United States since obtaining registration clearance from the U.S. Food […]
DUBAI, UAE, Jan. 23, 2024 /PRNewswire/ — Bybit, the world’s third largest crypto exchange by volume, is thrilled to announce the launch of the second generation of its innovative ByBUIDLERs Program. Building on the resounding success of its original program, Bybit aims to transform more individuals into influential content creators and community influencers in the […]
BANGKOK, Jan. 23, 2024 /PRNewswire/ — FBS, a leading global broker, underscores new opportunities for investors amid the historic highs of the US stock market in early 2024. Following the extraordinary rally of the US stocks at the end of 2023, public concerns about rising interest rates, economic growth slowdown, and tipping inflation went down, […]
KUALA LUMPUR, Malaysia, Jan. 23, 2024 /PRNewswire/ — FBS, a leading global broker, underscores new opportunities for investors amid the historic highs of the US stock market in early 2024. Following the extraordinary rally of the US stocks at the end of 2023, public concerns about rising interest rates, economic growth slowdown, and tipping inflation […]
PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existing alternatives in the United States. Amadix becomes the first European company to announce this recognition for early detection of colorectal cancer. MADRID, Jan. 23, 2024 /PRNewswire/ — Amadix, a Spanish biotech company, announced today that […]
SYDNEY, Jan. 23, 2024 /PRNewswire/ — ATFX is excited to announce the completion of the Change of Name for Rakuten Securities Australia Pty Ltd. From now on, the entity will be known as AT Global Markets (Australia) Pty Ltd, with the brand name “ATFX” to continue serving retail clients and the brand “ATFX Connect” to […]
